1OA Stock Chart & Stats
€0.01
€0.01(100.00%)
At close: 4:00 PM EST
€0.01
€0.01(100.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.02
Previous CloseN/A
Volume18.54K
Average Volume (3M)1.50K
Market Cap
€4.63M
Enterprise Value€5.08M
Total Cash (Recent Filing)€102.83K
Total Debt (Recent Filing)€227.48K
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume1,500
30 Day Avg. Volume1,500
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageA very low trailing debt-to-equity (~0.02) materially reduces financial risk and interest burden, giving the company durable flexibility to manage operations through cash shortfalls and pursue financing or strategic options without near-term solvency pressure.
Positive Gross MarginA positive gross margin near 32% indicates the core product economics can cover variable costs, providing a structural foundation for future operating leverage if revenue stabilizes and fixed costs are controlled, supporting long-term margin recovery potential.
Trend Improvement Vs Earlier LossesDocumented improvement versus the 2021–2022 period shows management has made operational progress that improved margins and reduced extreme losses; this trend, if sustained, provides a durable pathway toward stabilization and eventual profitability.
Bears Say
Sharp Revenue DeclineA dramatic TTM revenue decline (~-400%) is structurally damaging: it undermines scale economics, reduces ability to absorb fixed costs, weakens pricing power and makes cash generation unpredictable, raising longer-term viability and growth concerns absent revenue recovery.
Persistent Negative Cash FlowOngoing negative operating and free cash flow (~-0.42M TTM) means the company is burning cash to run operations; this persistency pressures liquidity, forces reliance on external financing or equity dilution, and constrains investment in R&D and commercialization over months.
Equity Erosion & Negative ReturnsSevere erosion of equity reduces the balance-sheet buffer for losses and limits financial flexibility despite low debt; declining shareholder equity and negative returns signal sustained value destruction and heighten risk that the business will need recapitalization.
Blueberries Medical News
1OA FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was <€0.01 and its highest was €0.02 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is €4.63M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Sep 02, 2026 which is in 39 days.
How were Blueberries Medical Corp’s earnings last quarter?
Currently, no data Available
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in DE:1OA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.